nonobese diabetic mouse
Recently Published Documents


TOTAL DOCUMENTS

116
(FIVE YEARS 0)

H-INDEX

30
(FIVE YEARS 0)



2019 ◽  
Vol 21 (1) ◽  
pp. 71-77 ◽  
Author(s):  
Janice M. Nieves-Bonilla ◽  
Badr Kiaf ◽  
Cornelia Schuster ◽  
Stephan Kissler


The Prostate ◽  
2019 ◽  
Vol 79 (9) ◽  
pp. 980-993 ◽  
Author(s):  
LaTayia M. Aaron‐Brooks ◽  
Takeshi Sasaki ◽  
Renee E. Vickman ◽  
Lin Wei ◽  
Omar E. Franco ◽  
...  


2019 ◽  
Vol 5 (5) ◽  
pp. 2631-2646 ◽  
Author(s):  
Jamal S. Lewis ◽  
Joshua M. Stewart ◽  
Gregory P. Marshall ◽  
Matthew R. Carstens ◽  
Ying Zhang ◽  
...  


2017 ◽  
Vol 1 (S1) ◽  
pp. 37-37
Author(s):  
Andrea Lin ◽  
Clayton Mathews ◽  
Michael Haller ◽  
Todd Brusko ◽  
Mark Atkinson ◽  
...  

OBJECTIVES/SPECIFIC AIMS: Understand the immunomodulatory effects of anti-thymocyte globulin (ATG) and granulocyte colony stimulating factor (G-CSF) on type 1 diabetes patients using samples and in the preclinical model, the nonobese diabetic mouse. METHODS/STUDY POPULATION: Flow cytometry analysis of phase 1 peripheral blood samples treatment of nonobese diabetic mouse with ATG and GCSF and flow cytometry analysis of immune organs (spleen, lymph nodes, blood, bone marrow). RESULTS/ANTICIPATED RESULTS: Changes in both innate and adaptive immune cell subsets including plasmacytoid dendritic cells, naive, memory, effector CD4+ and CD8+ T-cells, and CD4+ T-regulatory cells and CD8+ T-regulatory cells DISCUSSION/SIGNIFICANCE OF IMPACT: Understanding of immune cell targets for immunotherapy in new-onset type 1 diabetes patients.



2017 ◽  
Vol 95 (8) ◽  
pp. 684-694 ◽  
Author(s):  
Jennifer Y Barr ◽  
Xiaofang Wang ◽  
David K Meyerholz ◽  
Scott M Lieberman


2015 ◽  
Vol 99 (6) ◽  
pp. 1131-1140 ◽  
Author(s):  
Fei Xia ◽  
Hui Cao ◽  
Jiao Du ◽  
Xiulan Liu ◽  
Yang Liu ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document